Product Name :ATRAID polyclonal antibody
Application_all :WB (1/500 - 1/1000)
Background :All-trans retinoic acid-induced differentiation factor: Promotes osteoblast cell differentiation and terminal mineralization. Plays a role in inducing the cell cycle arrest via inhibiting CCND1 expression in all-trans-retinoic acid (ATRA) signal pathway. In osteoclasts, forms a transporter complex with ATRAID for nitrogen-containing-bisphophonates (N-BPs) required for releasing N-BP molecules that have trafficked to lysosomes through fluid-phase endocytosis into the cytosol
Product :1mg/ml in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Purification&Purity :The antibody was purified by immunogen affinity chromatography.
Storage&Stability :Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :Recognizes endogenous levels of ATRAID protein
Note :For research use only, not for use in diagnostic procedure.
Alternative Name :APR3; C2orf28; All-trans retinoic acid-induced differentiation factor; Apoptosis-related protein 3; APR-3; p18
Immunogen :A synthetic peptide encompassing a sequence within the N-terminal region of human ATRAID.
Modification :Unmodification
